Skip to content

Insider · CIK 0001202993

Mohsin Y Meghji

chairofficerdirector

Files at VLOS (M3-Brigade Acquisition V Corp.). First filing -, latest -.

Mohsin Y Meghji files SEC Form 4 as chair and director at VLOS (M3-Brigade Acquisition V Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Mohsin Y Meghji has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 27, 2025VLOS
M3-Brigade Acquisition V Corp.
SOpen-market sale
Class B ordinary sharesderivativeindirect: By M3-Brigade Sponsor V LLC
-7,187,500--0May 29, 2025

Questions about Mohsin Y Meghji

Answered from the filings on this page, as of the latest one.

Is Mohsin Y Meghji buying or selling?

Mohsin Y Meghji has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Mohsin Y Meghji's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mohsin Y Meghji has 0.

Where does Mohsin Y Meghji file Form 4?

Mohsin Y Meghji has filed Form 4 at VLOS (M3-Brigade Acquisition V Corp.) as Executive Chairman of BOD. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.